Cipla launches COVID-19 drug remdesivir in India as disease takes holdEfforts to get Gilead’s experimental COVID-19 drug remdesivir to patients in badly-hit India are building after drug maker Cipla announced it Share XCipla launches COVID-19 drug remdesivir in India as disease takes holdhttps://pharmaphorum.com/news/cipla-launches-covid-19-drug-remdesivir-in-india-as-cases-mount/
Sanofi to combat shortages with European medicines ingredient firmSanofi is to create a European company focused on production and marketing of active pharmaceutical ingredients (API) – Share XSanofi to combat shortages with European medicines ingredient firmhttps://pharmaphorum.com/news/sanofi-to-combat-shortages-with-european-medicines-ingredient-firm/
Cipla taps Wellthy for digital therapeutics expertiseIndian pharma company Cipla has made another play in the digital medicine category by taking a near-12% stake Share XCipla taps Wellthy for digital therapeutics expertisehttps://pharmaphorum.com/news/cipla-taps-wellthy-for-digital-therapeutics-expertise/
